4D Molecular Therapeutics prices $120M share offering
- Clinical-stage biotherapeutics company, 4D Molecular Therapeutics (NASDAQ:FDMT) upsized underwritten public offering of 7.5M shares at a public offering price of $16.00 per share.
- Underwriters have a 30-day option to purchase up to an additional ~1.13M shares of common stock at the public offering price, less underwriting discounts and commissions.
- Gross proceeds from the offering are expected to be $120M
- The offering is expected to close on May 9, 2023